Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Wednesday, July 1

I g PS *,SS I S T1

32158 Thrombocytopenia in HIV-infected patients
Tengiz Tsertsvadze*; M.D. Butsashvili; G. Kamkamidze, Georgia
32159 AIDS-associated lymphoma. Results of the treatment in 36 cases
Leopoldo Nieto*; S. Trevifio; G. Luna; A. Majluf, Mexico
32160 Thrombocytopenia in Paediatric HIV-infection
Rodica Costa*; M. Serban; A. Isac; A. Rosca; S. Arghirescu, Romania
32161 Anemia associated with HIV-infection in children
Jeanette Balbaryski*; Eduardo Gaddi; Susana Laucella; Claudio
Cantisano; Graciela Barboni; Marcela Candi; Vera Giraudi, Argentina
32162 Determinants of increased energy expenditure in
HIV-infected women
Steven K. Grinspoon, USA
32163 Testosterone, HIV activity, and nutritional status in
HIV-infected women
Julian Falutz*;L. Callow, Canada
32164 Treatment of dorsocervical fat pads and truncal adiposity with
serostim (recombinant human growth hormone] in patients with
AIDS maintained on HAART
Ramon Torres, USA
32165 Tumor necrosis factor response to megestrol acetate therapy in
AIDS-associated wasting
Francisco Arnalich*; RL. Martinez-Hernandez; A. Hernanz;
C. Montiel;J. Camacho; C. Fernandez-Capitan; J. Gonzalez-Garcia, Spain
32166 Effect of a high protein diet upon protein metabolism in
HIV-infected men and women
Ellen S. Engelson*; D.R Kotler; I. Schur; D.E. Matthews, USA
32167 HIV RNA, CD4+ cell count, and immune activation markers predict HIVrelated wasting prior to AIDS in the Multicenter AIDS Cohort Study
(MACS)
Robert H. Lyles*; A.M. Tang; J. W Mellors; J.B. Margolick; B.R. Visscher;
J.P Phair; N.M.H. Graham, USA
32168 Increased Resting Energy Expenditure (REE) is associated
with increased plasma HIV RNA
Abby Shevitz*; D.L. Spiegelman; JK. French; R. Roubenoff;
TA. Knox; G.L. Gorbach; PR. Skolnik, USA
32169 Body composition in HIV-infected men and women in 1996-1997
(CPCRA 038)
Cynthia L. Gibert*; N. Muurahainen; G. Collins; B. Williams;
S. Raghavan; G. Bartsch; D. Wheeler, USA
32170 Open Label use of thalidomide in adults with HIV-associated wasting
(Protocol W-002)
Steve Thomas*; Kak Kook; J.C.F Fang, USA
32171 Comparative study of rifabutin absorption and disposition in HIVinfected patients with or without wasting syndrome
Giorgio Gatti*; A. Di Biagio; C. De Pascalis; M. Guerra; M. Bassetti;
D. Bassetti, Italy
32172 Protease inhibitor-associated hyperglycemia: Results of switching from
indinavir to nelfinavir
Michael P. Dube*; D.L.J. Johnson; J.S.C. Currier; J.M.L. Leedom, USA

32173 Alterations in body fat distribution in HIV-infected men and women
Donald P Kotler*; K.B. Rosenbaum; J. Wang; R.N. Pierson, Jr., USA

32174 Hypogonadism and wasting In the era of HAART in HIV-infected patients
Daniel Berger*; N. Muurahainen; H. Wittert; G. Bucher; B.E. Baker;
J.P Balser, USA
32175 HIV-infection affects the expression offructose-6-phosphate,
2-kinase/fructose-2,6-bisphosphatase
Masashi Fukasawa*; A. Okumura; N. Shinomiya; M. Rokutanda;
R. Sakakibara, Japan
32176 Long-term Effects of androgen administration in men with AIDS
wasting
Steven K. Grinspoon*; C Corcoran; E. Anderson; D. Schoenfeld; N. Basgoz;
A. Klibanski, USA
32177 Impact of protease inhibitor treatment on body composition and
prevalence of malnutrition in HIV-positive outpatients
Achim Schwenk; A. Beijenherz; G. Kremer; H. Steuck; B. Salzberger;
V Dielh; G. Faetkenheuer, Germany
32178 The key role of stress hormones during paediatic HIV-infection:
Three years of follow-up
Mariangela Rondanelli*; D. Caselli; A. Maccabruni; M. Maghnie;
L. Bacchella; A. De Stefano; E. Ferrari, Italy
32179 Growth hormone produces striking anabolic effects in an HIV-infected
adolescent with failure-to-thrive and wasting
Mitchell E. Geffner*; D. Dreimane; K. Nielsen; P Krogstad; E.R. Stiehm;
YJ. Bryson, USA
32180 Change in log10 HIV RNA & protease inhibitor use associated with
weight change in HIV+ men in a National Clinical Trial
Subhasree Raghavan*; Lisa B. Grant; Glenn Barisch; Melanie Thompson;
Bruce Williams; Noe Matoe; Wafaa M. EI-Sadr, USA
32181 Altered body fat distribution in HIV-infection:
Regional body composition measurements by whole body
MRI and DXA scans
Ellen S. Engelson*; D.P Kotler; Y.X. Tan; D. Agin; B. Bashist; J. Wang;
S.B. Heymsfield, USA
32182 Preservation of restored body cell mass (BCM) and phase angle after
discontinuation of human growth hormone (r-hGH; Serostim )
Patrick M. Nemecheck*; Jennifer Stolifer; Lisa Sackuvich, USA
32183 Lack of change in body weight and body composition in
HIV+ individuals without wasting who initiate maximally
suppressive antiretroviral therapy
James Hellinger*; B.S. Kim; B. Dionian; CJ. Cohen; R. Zackin, USA
32184 Stool weight is associated with weight loss in patients with
chronic diarrhea
Jamey Maimares Schmidt*; S. Porter; L. Kim; M. Keiserman;
M. Holodniy; J. Koch, USA
32185 Anabolic steroids, resistance exercise and protein supplementation
effect on lean body mass in HIV+ patients
Nelson R. Vergel*; P Salvato; M. Mooney, USA
32186 Evaluation of serial observations of weight and body composition
changes in HIV+ patients
Cade Fields-Gardner*; K. Jennings, USA
32187 Urinary excretion of retinol, a-tocopherol and malondialdehyde
in HIV-1 infected individuals and patients with AIDS

Helio Vannucchi* J.FC. Figueiredo; M.V.M. Junqueira Franco;
A.A. Jordao, Jr., Brazil

140

12th World AIDS Conference Geneva